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Abstract—Adaptive, model-free control of Type 1 Diabetes
Mellitus (T1DM) is a lack in the field of diabetes control, since,
most of the applied control strategies are model-based ones. The
main problem is that difficult to formulate exact mathematical
models to replicate the physiological processes, not just because
of their behavior, rather then these processes are changing
patient-by-patient. Furthermore, the developed models so far, are
highly non-linear and difficult to manage. A possible adaptive
control solution can be the recently developed Robust Fixed Point
Transformation (RFPT)-based control design method, which can
provide control action, based on the observations about the actual
output of a controlled system. In this paper we show a survey,
how can be used this novel technique related with a known, high-
order glucose-insulin model, to investigate the usability according
to diabetes control.
Index Terms—Robust Fixed-Point Transformation, RFPT,
T1DM, Control of Diabetes
I. INTRODUCTION
Diabetes Mellitus (DM) is a sub-group of the so-called
Chronic Metabolic Diseases (CMD), connected to the insulin
hormone, which is the key compound of the glucose uptake
by several types of body cells [1]. Glucose, beside other low
complex carbohydrates (CHO(s)) provides the energy for most
of the human body cells, among others, through the Citric-Acid
cycle.
The most dangerous type of DM is Type 1 DM (T1DM),
which occurs when the insulin producer β-cells of the pancreas
are annihilated by an autoimmune reaction. Hence, because of
the lack of insulin, the insulin-dependent cells of the human
body are going to be suffer energetic deficit on short term and
energetic collapse over time [2].
Modeling and control have absolute relevance on the dia-
betes research field. The main problems are associated with
the fact that the physiological processes in human body are
non-linear, thus, the control design is not trivial and demands
individual approach case-by-case [3].
Taking into account that it is very difficult to precisely
modeling and identifying any physiological processes, nonlin-
ear, robust or adaptive control solution can provide appropriate
control action based on approximate model of the real system.
One of the most common non-linear technique is based on
Lyapunov’s 2nd law [4], but this is difficult to handle mathe-
matically. Frequently used non-linear techniques are the Non-
linear Model Predictive Control (NMPC) [5], Soft Computing
techniques [6], [7], and Linear Parameter Varying (LPV) based
robust control methods [8]–[10]. Adaptive controllers can
nicely adapt themselves to need of the system under control
by observing its behavior, like the Model Reference Adaptive
Control (MRAC) [11].
In this paper we investigate how the recently developed
RFPT based control design can give a useful solution to
diabetes control [12], [13]. This method has several benefits
that will be detailed below.
The paper is structured as follows. First, we give a short
introduction about the handled problem. Following that we
present the investigated T1DM model and the control method
applied to it. At last, we summarize our results, draw the
conclusions, and outline a perspective for the future work.
II. T1DM MODEL
During the investigations, we used a well-known, high order
digestion (1) and T1DM (2) models, presented by [14]–[17].
Also, this models are the base of the UVA/Padova simulator
[18]. The model schematic figure are represented by Fig. 1.
Q˙sto(t) = Qsto1(t) +Qsto2(t)
Q˙sto1(t) = −kgriQsto1(t) + d(t)
Q˙sto2(t) = −kgut(t, Qsto)Qsto2(t) + kgriQsto1(t)
Q˙gut(t) = −kabsQgut(t) + kgut(t, Qsto)Qsto2(t)
Ra(t) =
fkabsQgut(t)
BW
.
(1)
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G˙M (t) = −kscGM (t) +
ksc
VG
Gp(t)
G˙p(t) = EGP (t) +Ra(t)− Uii − E(t)−
−k1Gp(t) + k2Gt(t)
G˙t(t) = −Uid + k1Gp(t)− k2Gt(t)
X˙t(t) = −p2UX(t) + p2U [I(t)− Ib]
I˙d(t) = −kiId(t) + kiI1(t)
I˙1(t) = −kiI1(t) + kiI(t)
I˙p(t) = −(m2 +m4)Ip(t) +m1Il(t) + ka2S2(t)+
+ka1S1(t)
I˙l(t) = m2Ip(t)− (m1 +m3)Il(t)
S˙2(t) = −ka2S2(t) + kdS1(t)
S˙1(t) = −(ka1 + kd)S1(t) + u(t) .
(2)
Figure 1. The schematic structures of the used models [(a) High-order T1DM
model, (b) Complex digestion model]
The unified complex model has two inputs and one out-
put, namely, u(t) [pmol/kg/min] is the injected insulin, d
[mg/min] is the amount of ingested glucose and GM (t) [mg/dl]
represents the subcutaneous glucose level. Other details are
available in the cited literature.
III. APPLIED CONTROL METHOD
The basic idea of the RFPT-based adaptive control is
the concept of the ”response function” that belongs to the
compound consisting of the ”rough initial model in use”
and the ”actual physical system under control”. For a purely
kinematically formulated ”desired response” of the controlled
system rDes the necessary control signal is designed by the
use of the approximate model. By applying this control signal
on the actual system, its realized response, rReal, will be a
function of rDes as rReal = f
(
rDes
) = rDes due to the
modeling errors and the unknown external disturbances. The
task is to find the appropriate input r to which the situation
rDes = f (r) belongs. Normally r can be found as the
limit of a sequence obtained by the iterative application of
a contractive map as rn+1 = G
(
rn; r
Des
)
that is composed
by the use of the response function f . (The discrete steps
correspond to the digital cycles of the controller.) The RFPT-
based design corresponds to giving a particular choice for
the function G. The convergence of the so obtained sequence
depends partly on the parameters of G and partly on the
behavior of f . It was shown that for a wide class of physical
systems this convergence can be guaranteed by properly setting
the parameters of G if ∂f∂r satisfies some simple requirements
[19]. The mathematical background corresponds to Banach’s
”Fixed Point Theorem” [20] that states that the limit value of
an iterative sequence {xn+1 = G(xn)} generated a contractive
map G : n → n on a linear, normed, complete metric space
(Banach space) is the fixed point of G satisfying the equation
G(x) = x. For Single Input - Single Output (SISO) systems
rn+1 = G(rn; r
Des)
def
= (rn +Kc)×{
1 +Bc
[
tanh(Ac(f(rn)− rDes))
]}−Kc (3)
where Kc, Ac, and Bc = ±1 are the adaptive control
parameters. Evidently we have two fixed points as r = −Kc
(that is trivial and cannot used in the control), and r for
which f(r) = rDes, that is the solution of the control
task. For convergence the
∣∣∣dfdr
∣∣∣ < 1 condition must be met.
Further explanation on appropriate setting the adaptive control
parameters can be found in [13].
IV. CONTROLLER DESIGN
A. Specifics of the Model
During the development, quite a few general control, phys-
iological and phenomenological constraints have to be consid-
ered, as listed below:
• With the caveats that each of the state variables de-
notes the concentration of certain chemical component,
therefore ot must have either positive value, or after the
depletion of the appropiate component- it must ramain
zero. These ”truncation-type” nonlinearities make the
application of any ”linearization” dubious, whenever a
given component is depleted. This fact seriously concerns
any considerations related to the frequency domain that
can widely used in the case of linear more or less
linearizable systems. In the sequel qualitative analysis of
present model is given.
• Each time-constant model parameter should be positive.
• Each state variable has its own exponential decay con-
stant.
• Any coupling between the coupled pairs of state variables
is of exponential nature: the decrease in the concentration
of given state variable generates increase in that of the
coupled one and vice-versa.
• Without finite input or extraction terms all the state
variables should converge to zero.
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• The state propagation quantities as X˙, I˙d, I˙1, I˙p, I˙L, S˙2
and S˙1 are completely independent of the state variables
GM , Gp and Gt.
• Each element of the state propagation group G˙M , G˙p and
G˙t directly is concerned by the input R˙a and the state
variables X and I˙d belonging to the other group.
• To sum up, u > 0 makes X increase. Increasing X
decrease G˙t and Gt. Decreasing Gt decreases G˙p due to
which (2) gives possibility for decreasing GM by properly
big insulin input u. It is important to note that depletion
of X -since dotX = 0 if X = 0- makes any possibility
for controlling GM via u cease. This introduces a strong
nonlinear asymmetry into the system: drastic glucose Ra
drastically increase GM , via drastic insulin input u its
effect can be contained.
• From 1 it is evident that u is directly related to a high
order time-derivative of the directly measureable state
variable GM .
B. The Effect chain of Control Action
To design the Rough Model (RM), which provides the
control signal, the effect chain of injected insulin (which is the
control signal) need to be mapped. This route defines, how can
we affect on the operation of the system, without knowledge
of the actually happening inside the system.
Figure 2. Effect chain of insulin
Fig. 2. shows the concrete effect chain of injected insulin
u(t). The physiological model specialties determine that how
the injected insulin affects on the GM (t), namely, through the
insulin-dependent glucose utilization (Uid), which is the glu-
cose uptake by insulin-dependent tissues and the endogenous
glucose production of the liver (EGP ), thus, the inhibition of
gluconeogenesis.
C. Design of Rough Model
It can be concluded based on the IV-B that a kinematic
prescription (which is used by the RFPT-method) are not
expedient in this case, since, the relative order of the control
chain is at least 8. That means, the kinematic prescription
should be contains the 8th time derivative of the GM , at the
same time, the required order of the control law should be 8
as well, in order to handle this high derivative. To avoid this
unpleasant effect, other approaches should be used. A possible
solution, if the exact model is ”hided”, as a black box and
only the input and output are investigated. Naturally, this step
is reducing the accuracy of the control, nevertheless, it can be
used, because of the adaptivity of the method. If the steady
state of the system can be approached over one cycle and the
GM is available at the end of this cycle, the necessary insulin
input which is need to be injected at the next cycle can be
calculated by the controller. However, this condition is not
usable itself, because of the glucose input dynamics is faster
then the system’s settling characteristics. Therefore, a simple
dynamic scheme has to be developed, which can describes not
only the Δu˜ determined by the actual glucose input, but also
the takes into account the affect of the past control actions
on the actual condition beside the appropriate time delays,
determined by the system’s dynamics. Here, we supposed that
the Ra is known, since the glucose input is regulated by us
and based on the (1), the G˜M (u˜; R˜a) can be calculated. The
selected equation is a quite simple one,
GM (t) ≈ a u(t) + b . (4)
Let u˜ ∈ [250, 600] and G˜M is calculated, where R˜a = 60n,
where n ∈ {0..15} integer. Based on (4), with numerical ap-
proximation, the a and b are calculable. To reduce complexity,
a second order polynomials can be fitted on the a(Ra) and
b(Ra) which occurred with the calculation of a and b.
Figure 3. Results of curve fittings based on (4) (for example, beside n = 0,
R˜a = 0, u˜min = 250 and u˜max = 600), then G˜M,stac(umin) ≈ 200 and
G˜M,stac(umax) ≈ 40, the numerical calculation gives aest = −0.46 and
best = 314.29).
Due to the fact, that the polynomials are known, Δu˜ can
be estimated by:
ΔGDesiredM (t) ≈
da(Ra)
dRa
ΔRau˜ + a(Ra)Δu˜ +
+
db(Ra)
dRa
ΔRa ,
(5)
where ΔG˜DesiredM (t) denotes the changing of the desired
subcutaneous glucose level determined by the measurements.
The prescribed approximation for ΔG˜DesiredM (t) is ”purely”
kinematic and contains several simplification from the control
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point of view. These simplifications are occurring as strong
constraints during the control and the inaccuracies should be
controlled by the adaptivity law.
The RM can be constructed with using the second order
polynomials and combine with (1), (4) and (5):
u˙Desired =
GM + G˙
Desired
M − a(Ra)u− b(Ra)
a(Ra)
−
−
da(Ra)
dRa
u− db(Ra)
dRa
a(Ra)
(6)
The RM, according to the (6) gives an estimation about the
GM and u and provides the control signal as well. The tuning
parameters are the specifics of the polynomials, a(Ra) and
b(Ra). These approximation includes that physical constraint
at the same time that the control signal, namely, the injected
insulin cannot be negative. It can be seen, that finally, the
changing of the desired insulin level is determined by the
followings:
• Actual BG measurements (GM ), which are available at
every 5 minutes. We used this value, because the CGMS
systems on the market are operating with this sampling
time.
• The changing of the desired BG level (G˙M ), affected by
the control law.
• The used polynomials and the changing of them, affected
by the u. Furthermore, the polynomials are determined
by the glucose input, which is a good approximation of
the reality, where the insulin dosing is determined by the
ingested food, namely, the glucose input.
D. Control Law
The control law can be formalized with the kinematic
requirements. Due to the RM is a second order model, the
control law should be a second order one as well. From
simplicity reasons we implemented a ”Fixed Set-Point type of
Control” with GN as set-point parameter. The tracking error
is taken as a prescription and such a PID kind feedback with
a proportional term Λ > 0 could be suitable:
(
d
dt
+ Λ)3
t1∫
t0
(
GN (ξ)−G(ξ)) dξ = 0 (7)
where GN (t) is the nominal blood glucose concentration
of the nominal model, G(t) is the realized blood glucose
concentration and the exact requirement is that the error signal,
GN (t)−G(t), should converge to zero as t → ∞. Naturally,
the fixed-set point control determines that the derivatives of
GN will be zero. With mathematical transformations of (7),
the desired GM derivate is equal to
G¨DesiredM (t) =
(
d
dt
)2
GN (t)+
+
2∑
s=0
(
3
s
)
Λ3−s
(
d
dt
)s t1∫
t0
(
GN (ξ)−G(ξ))dξ .
(8)
where GN (t) is the BG concentration of the nominal model,
G(t) is the realized blood glucose concentration and the exact
requirement is that the error signal, GN (t) − G(t), should
converge to zero as t → ∞. Naturally, the fixed-set point
control determines that the derivatives of GN will be zero.
We implemented a ”forgetting integral”, because the former
tracking errors were considered with lower weight to dismiss
the overload of the integrated error. The changing of G˙DesiredM
is reflecting in the RM and affects the injected insulin level at
every cycle.
E. Adaptivity Law
The suggested adaptivity law from [13] is the (3). We
selected an other adaptivity law, which also satisfies the
mathematical requirements of the RFPT-based method, which
was the following:
rn+1 = G(rn; r
Des)
def
= (rn +Kc)×{
1 +Bc
[
Ψ(Ac(f(rn)− rDes))
]}−Kc (9)
where Kc, Ac, and Bc = ±1 are the adaptive control
parameters and Ψ is a sigmoid function (similar properties
as the hyperbolic tangent), namely Ψ(x) =
x
1 + |x|.
F. Control scheme
Fig. 4. shows the schematic control structure of the sys-
tem. The RFPT-based methodology is clearly visible on this
figure, thus, the control action is based on the known input
and the measurable output of the system and the controller
does not have knowledge about the inside conditions of the
controlled system. This philosophy has absolute relevance for
the physiological systems, where exact knowledge about the
inside operation of the controlled system is not available.
G. Constraints of Usability
In this given case, several constraints need to be considered
which come from the used models and adapted control scheme,
detailed below.
1) Constraints about the used models: The selected patient
model is a high order and complex one, with different inside
dynamics at glucose and insulin subsystems. The insulin
affects on the glucose subsystem through a complex route.
We implemented the model with the data given by [14]–[17],
without identification, which take in further uncertainty to the
system. We have considered, that the input of the patient
model is known at every moment, which is a simplification
as well, since, the real system’s input is the ingested food
(here, the dosed amount of glucose (d(t))), not the absorbed
glucose from the gastrointestinal system (Ra(t)). The goal of
this simplification was to describe more accurate the patient
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Figure 4. Schematic structure of the control environment
model’s dynamics with the rough model, the d(t) also can be
used for this purpose.
2) Constraints about the used control scheme: The most
advantage of the RFPT-based method, namely, the model-
free approach, it appears as a disadvantage in the accuracy,
which is the natural consequence of the fact that the controller
does not know anything about the controlled system’s inside
operation. The applied method to catch the dynamics of the
patient model includes inaccuracies, since, we not used the
patient model during the designing of the RM. The used
second order polynomials from simplification reason is not
to accurate and the whole system has other inside dynamical
effects, which are not necessarily reflecting in this solution.
The adaptive controller is responsible to maintain the side-
effects of the simplifications and inaccuracies through gives
information about the required of control signal to reach the
control goals. The main constraint with the adaptive controller
is the optimization of the control parameters, which requires
an individual approach case-by-case and the application will
determines it [21].
V. RESULTS
We have tested our solution with two glucose intake proto-
cols in the developed in-silico simulation environment with
different length. The first glucose intake protocol was the
following: 8 am, 50 g; 13 pm, 70 g; 20 pm, 70 g. This sequence
is repeating over a week, the total simulation time was 168
hours. The result can be seen on Fig. 5.
The Fig. 5. shows, that the controller can handle the
appearing glucose (Ra(t)) and adapted to the requirements
of the system with injecting insulin to reach the prescribed
set-point value. The variables started from the steady-state
condition and after the initial transient relaxation, because of
the recurring input the system showed the expected recurring,
oscillating behavior.
The second glucose intake protocol was a randomized one
with various intake amounts and time-points. On Fig. 6. can be
seen, that after the initial transients, the controller adapting to
Figure 5. Result of a one week simulation with first feeding protocol [Control
parameters: Λ = 0.015, Actrl = 1 exp− 4, Kctrl = −1000, Bctrl = 1,
Set-point (GN )=100 mg/dL ]
the systems needs, however, because of the randomized intake,
this adoption is changing all the time, as we expected. The
initial values of the simulation were calculated based on 2,
beside 36 μU/mL (≈ 250 pmol/L), because we would have
liked to that the initial conditions not to be optimal. Clearly
visible, that the controller can handle the uncertainties like this.
The last figure shows a CVGA result (which is a frequently
used evaluating method in diabetes control [22]) of a 53
days long simulation with the following control parameters:
Λ = 0.0125, Actrl = 1 exp−3, Kctrl = −1000, Bctrl = −1.
The randomized intake parameters were: 3 glucose intake at
every 24 hours with taking into account that the virtual patient
feeding happens during the first 16 hours with minimum 4
hours between the each intakes; the amounts are changing
between 40 g and 70 g, randomly. The results is shown by
Fig. 7.
The Fig. 7. shows that the controller can handle this various
environment, however, the unfavorable randomized intakes are
degrades the adaptivity and producing higher deviation in the
daily maximum and minimum of BG levels.
VI. CONCLUSION AND FUTURE WORK
In this paper, our goal was to proof the usability of the
RFPT-based control design method in the field of diabetes
control. We investigated several situations and the simulations
were encouraging, we presented here three of them. The RFPT-
based method is appropriate from different point of views,
which were detailed in the text. In our future work, we are
going to investigate the design method from different direc-
tions, namely, we will examine the possibilities of parameter
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Figure 6. Result of a 255 hours simulation with second feeding protocol
[Control parameters: Λ = 0.0125, Actrl = 1 exp−3, Kctrl = −1000,
Bctrl = −1, Set-point (GN )=95 mg/dL ]
Figure 7. Result of a 255 hours simulation with second feeding protocol
[Control parameters: Λ = 0.0125, Actrl = 1 exp−3, Kctrl = −1000,
Bctrl = −1, Set-point (GN )=95 mg/dL ]
identification and optimization, control law and adaptivity
function selection and other point of views.
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